MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy.
about
Targeting immunosuppressive adenosine in cancer.Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma.Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings.Mechanisms of Resistance to PD-1 and PD-L1 Blockade.CD73 expression and clinical significance in human metastatic melanoma.
P2860
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MAPK Signaling and Inflammatio ...... of CD73 during Immunotherapy.
@en
type
label
MAPK Signaling and Inflammatio ...... of CD73 during Immunotherapy.
@en
prefLabel
MAPK Signaling and Inflammatio ...... of CD73 during Immunotherapy.
@en
P2093
P50
P1433
P1476
MAPK Signaling and Inflammatio ...... of CD73 during Immunotherapy.
@en
P2093
Antoni Ribas
Arabella Young
Bartomeu Bibiloni Ramis
Dirk Schadendorf
Dorys Lopez-Ramos
Hubert Schorle
Jason Madore
Jennifer Landsberg
Julia Reinhardt
Mark J Smyth
P304
P356
10.1158/0008-5472.CAN-17-0395
P407
P577
2017-06-26T00:00:00Z